Posts Tagged: Philadelphia

Brandywine Realty Trust eyes Metroplex in Plymouth Meeting for new life sciences buildings

Brandywine Realty Trust plans to develop a site at its Metroplex Corporate Center off Chemical Road in Plymouth Meeting for life sciences research and manufacturing space. The Philadelphia real estate investment trust is seeking approvals for a single-story, 100,000-square-foot building that would be used for manufacturing and another 125,000-square-foot building that would be designed for… Read more »

Aro Biotherapeutics is latest life sciences firm to take space at the Curtis

Aro Biotherapeutics has leased 27,208 square feet of space at the Curtis, joining a growing number of life sciences companies occupying space in the building that fronts Washington Square in Philadelphia. The biotechnology company will relocate out of BioLabs at the Cambridge Innovation Center in the University City Science Center. Aro’s commitment to the space… Read more »

Life sciences labs slated for part of former Hahnemann Hospital complex

Iron Stone Real Estate Partners, which recently acquired part of the former Hahnemann University Hospital complex, plans to offer one of the buildings as research and development laboratories for the Philadelphia region’s growing life sciences sector. The Hahnemann structure Iron Stone selected for labs had housed Hahnemann’s in-house labs. That gives it an advantage over… Read more »

Developer plans to transform Budd Co. site in Philadelphia into campus for life sciences manufacturing

The owner of the sprawling former Budd Co. property in Philadelphia plans to transform it into a biomanufacturing hub, seizing upon Philadelphia’s burgeoning life sciences sector and demand by companies that need the space. Backed by Centerbridge Partners, a New York private equity firm, Plymouth Group envisions a multi-phased, multiyear development of the site that… Read more »

Construction of Penn Medicine’s $1.5B Pavilion Nearing Completion

Penn Medicine

During the throes of the pandemic in the spring of 2020 and in the middle of constructing its new $1.5 billion hospital, Penn Medicine switched gears to focus on creating extra capacity at the building for a potential influx of Covid-19 patients. A little more than a year later, Penn Medicine’s Pavilion is in its… Read more »